Impax Laboratories, Inc.
Impax Confirms Patent Challenge Relating to RENAGEL® Tablets, 400 mg and 800 mg
Published in Medical Verdicts and Law Weekly, April 2nd, 2009
Impax filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic version of RENAGEL® with the U.S. Food & Drug Administration (FDA). Following receipt of the notice from the FDA that Impax’s ANDA had been accepted for filing, Impax notified the New Drug Application holder and patent owner of its paragraph IV certification.
On March 13, 2009, Genzyme filed suit for patent infringement against Impax...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AAA Michigan
AAA Michigan Urges Legislators to Keep Mandatory Helmet Law - AARP Pennsylvania
AARP Pennsylvania Pleased by House Committee Action - Adoodle, Inc.
NOXO - the Answer to Inhibiting Noxious Odors is Now Available from the Hitt Companies, HEAVY WEIGHT SUPPLIER OF THE YEAR - Adultcon
BBW Adult Actress Sue LA's Show, According to Adultcon - Advance Nanotech, Inc.
AVNA's Owlstone Named Finalist by AMA Association for Sensor Technology for its SENSOR Innovation Award 2009 - Advocates for Youth
'REAL' Sex Education for America's Youth - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
